Two Sigma Investments »

An2 Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $284k 132k 2.15
2024-03-31 $306k 94k 3.25
2023-12-31 $394k 19k 20.49

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Carnival Corp Unit 99/99/9999 Put Option (CCL)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A (META)
Carvana Cl A (CVNA)
Snowflake Cl A (SNOW)
Bristol Myers Squibb (BMY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Amazon (AMZN)
Robinhood Mkts Com Cl A (HOOD)
Uber Technologies Put Option (UBER)

View all positions for Two Sigma Investments

Top funds holding An2 Therapeutics

BML Capital Management
RA Capital Management
TCG Crossover Management
Henderson Group
Vanguard Group
Acuitas Investments
Renaissance Technologies
BlackRock
BlackRock
Goldman Sachs Group
Geode Capital Management
Ghost Tree Capital
Two Sigma Advisers
Two Sigma Investments
Bridgeway Capital Management

View all funds holding An2 Therapeutics